175 related articles for article (PubMed ID: 34982524)
1. Ultrasound-Enhanced Reactive Oxygen Species Responsive Charge-Reversal Polymeric Nanocarriers for Efficient Pancreatic Cancer Gene Delivery.
Zhang C; Chen J; Song Y; Luo J; Jin P; Wang X; Xin L; Qiu F; Yao J; Wang G; Huang P
ACS Appl Mater Interfaces; 2022 Jan; 14(2):2587-2596. PubMed ID: 34982524
[TBL] [Abstract][Full Text] [Related]
2. Reactive Oxygen Species (ROS)-Responsive Charge-Switchable Nanocarriers for Gene Therapy of Metastatic Cancer.
Xiang J; Liu X; Zhou Z; Zhu D; Zhou Q; Piao Y; Jiang L; Tang J; Liu X; Shen Y
ACS Appl Mater Interfaces; 2018 Dec; 10(50):43352-43362. PubMed ID: 30465424
[TBL] [Abstract][Full Text] [Related]
3. SAHA (vorinostat) facilitates functional polymer-based gene transfection via upregulation of ROS and synergizes with TRAIL gene delivery for cancer therapy.
Zhou X; Liu Z; Wang H; Liu X; Zhou Z; Tang J; Liu X; Zheng M; Shen Y
J Drug Target; 2019 Mar; 27(3):306-314. PubMed ID: 30188217
[TBL] [Abstract][Full Text] [Related]
4. Glutathione-Specific and Intracellularly Labile Polymeric Nanocarrier for Efficient and Safe Cancer Gene Delivery.
Wang G; Zhu D; Zhou Z; Piao Y; Tang J; Shen Y
ACS Appl Mater Interfaces; 2020 Apr; 12(13):14825-14838. PubMed ID: 32166948
[TBL] [Abstract][Full Text] [Related]
5. A pH-Responsive Charge-Reversal Drug Delivery System with Tumor-Specific Drug Release and ROS Generation for Cancer Therapy.
Xu C; Song R; Lu P; Chen J; Zhou Y; Shen G; Jiang M; Zhang W
Int J Nanomedicine; 2020; 15():65-80. PubMed ID: 32021165
[TBL] [Abstract][Full Text] [Related]
6. Biocompatible reactive oxygen species (ROS)-responsive nanoparticles as superior drug delivery vehicles.
Zhang D; Wei Y; Chen K; Zhang X; Xu X; Shi Q; Han S; Chen X; Gong H; Li X; Zhang J
Adv Healthc Mater; 2015 Jan; 4(1):69-76. PubMed ID: 25147049
[TBL] [Abstract][Full Text] [Related]
7. Sequential-targeting nanocarriers with pH-controlled charge reversal for enhanced mitochondria-located photodynamic-immunotherapy of cancer.
Peng N; Yu H; Yu W; Yang M; Chen H; Zou T; Deng K; Huang S; Liu Y
Acta Biomater; 2020 Mar; 105():223-238. PubMed ID: 31926335
[TBL] [Abstract][Full Text] [Related]
8. Preparation of multifunctional nanobubbles and their application in bimodal imaging and targeted combination therapy of early pancreatic cancer.
Yang H; Zhao P; Zhou Y; Li Q; Cai W; Zhao Z; Shen J; Yao K; Duan Y
Sci Rep; 2021 Mar; 11(1):6254. PubMed ID: 33737559
[TBL] [Abstract][Full Text] [Related]
9. Recent advances on biocompatible and biodegradable nanoparticles as gene carriers.
Mokhtarzadeh A; Alibakhshi A; Yaghoobi H; Hashemi M; Hejazi M; Ramezani M
Expert Opin Biol Ther; 2016 Jun; 16(6):771-85. PubMed ID: 26998622
[TBL] [Abstract][Full Text] [Related]
10. Codelivery of CPT and siPHB1 with GSH/ROS Dual-Responsive Hybrid Nanoparticles Based on a [12]aneN
Liang YX; Sun XY; Xu DZ; Gao YN; Tang Q; Lu ZL; Liu Y
ACS Appl Bio Mater; 2024 May; 7(5):3202-3214. PubMed ID: 38651918
[TBL] [Abstract][Full Text] [Related]
11. Cinnamaldehyde-Based Poly(ester-thioacetal) To Generate Reactive Oxygen Species for Fabricating Reactive Oxygen Species-Responsive Nanoparticles.
Xu L; Zhao M; Zhang H; Gao W; Guo Z; Zhang X; Zhang J; Cao J; Pu Y; He B
Biomacromolecules; 2018 Dec; 19(12):4658-4667. PubMed ID: 30418756
[TBL] [Abstract][Full Text] [Related]
12. Reactive oxygen species activated nanoparticles with tumor acidity internalization for precise anticancer therapy.
Deng H; Zhao X; Deng L; Liu J; Dong A
J Control Release; 2017 Jun; 255():142-153. PubMed ID: 28385677
[TBL] [Abstract][Full Text] [Related]
13. Fusogenic Reactive Oxygen Species Triggered Charge-Reversal Vector for Effective Gene Delivery.
Liu X; Xiang J; Zhu D; Jiang L; Zhou Z; Tang J; Liu X; Huang Y; Shen Y
Adv Mater; 2016 Mar; 28(9):1743-52. PubMed ID: 26663349
[TBL] [Abstract][Full Text] [Related]
14. Glutathione and Reactive Oxygen Species Dual-Responsive Block Copolymer Prodrugs for Boosting Tumor Site-Specific Drug Release and Enhanced Antitumor Efficacy.
Yin W; Ke W; Lu N; Wang Y; Japir AAMM; Mohammed F; Wang Y; Pan Y; Ge Z
Biomacromolecules; 2020 Feb; 21(2):921-929. PubMed ID: 31961134
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial targeted doxorubicin derivatives delivered by ROS-responsive nanocarriers to breast tumor for overcoming of multidrug resistance.
Zhong XC; Shi MH; Liu HN; Chen JJ; Wang TT; Lin MT; Zhang ZT; Zhou Y; Lu YY; Xu WH; Gao JQ; Xu DH; Han M; Chen YD
Pharm Dev Technol; 2021 Jan; 26(1):21-29. PubMed ID: 33070673
[TBL] [Abstract][Full Text] [Related]
16. Oxygen-Self-Produced Nanoplatform for Relieving Hypoxia and Breaking Resistance to Sonodynamic Treatment of Pancreatic Cancer.
Chen J; Luo H; Liu Y; Zhang W; Li H; Luo T; Zhang K; Zhao Y; Liu J
ACS Nano; 2017 Dec; 11(12):12849-12862. PubMed ID: 29236476
[TBL] [Abstract][Full Text] [Related]
17. Light-Responsive Nanoparticles for Highly Efficient Cytoplasmic Delivery of Anticancer Agents.
Wang Y; Deng Y; Luo H; Zhu A; Ke H; Yang H; Chen H
ACS Nano; 2017 Dec; 11(12):12134-12144. PubMed ID: 29141151
[TBL] [Abstract][Full Text] [Related]
18. Reduction-Responsive and Multidrug Deliverable Albumin Nanoparticles: An Antitumor Drug to Abraxane against Human Pancreatic Tumor-Bearing Mice.
Hirakawa N; Ishima Y; Kinoshita R; Nakano R; Chuang VTG; Ando H; Shimizu T; Okuhira K; Maruyama T; Otagiri M; Ishida T
ACS Appl Bio Mater; 2021 May; 4(5):4302-4309. PubMed ID: 35006842
[TBL] [Abstract][Full Text] [Related]
19. Dual-responsive doxorubicin-loaded nanomicelles for enhanced cancer therapy.
Zhang X; Zhu T; Miao Y; Zhou L; Zhang W
J Nanobiotechnology; 2020 Sep; 18(1):136. PubMed ID: 32972412
[TBL] [Abstract][Full Text] [Related]
20. Enzymatic multifunctional biodegradable polymers for pH- and ROS-responsive anticancer drug delivery.
Su M; Xiao S; Shu M; Lu Y; Zeng Q; Xie J; Jiang Z; Liu J
Colloids Surf B Biointerfaces; 2020 Sep; 193():111067. PubMed ID: 32388121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
